TOPIGEN PHARMACEUTICALS INC has a total of 35 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are GUNTAKA RAMAREDDY V, IDERA PHARMACEUTICALS and OMNICYTE LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | Australia | 4 | |
#3 | Canada | 4 | |
#4 | China | 4 | |
#5 | United States | 4 | |
#6 | Brazil | 3 | |
#7 | Mexico | 3 | |
#8 | WIPO (World Intellectual Property Organization) | 3 | |
#9 | Republic of Korea | 2 | |
#10 | Japan | 1 | |
#11 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Renzi Paolo | 20 |
#2 | Paquet Luc | 15 |
#3 | Ferrari Nicolay | 13 |
#4 | D Anjou Helene | 13 |
#5 | Zemzoumi Khalid | 9 |
#6 | Damha Masad | 5 |
#7 | Anjou Helene D | 2 |
#8 | Paolo Renzi | 2 |
#9 | Allakhverdi Zoulfia | 1 |
#10 | Damha Masad J | 1 |
Publication | Filing date | Title |
---|---|---|
EP2285961A1 | Oligonucleotides for treating inflammation and neoplastic cell proliferation | |
US2009088411A1 | No-donating corticosteroid with improved pharmacokinetic, anti-inflammatory and vasodilatory properties | |
US2010048673A1 | Oligonucleotides affecting expression of phosphodiesterases | |
CN101351231A | Small interfering ribonucleic acid duplexes comprising arabinose modified nucleotides | |
US2009298913A1 | Small interfering oligonucleotides comprising arabinose modified nucleotides | |
CN101087623A | Antisense oligonucleotides for treating allergy and neoplastic cell proliferation |